Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Turkey register with Saglik Bilimleri Universitesi Gulhane Tip Fakultesi as lead sponsor. Synced 17 Nov 2026
7Current trials
2Recruiting now
0Drugs in these trials
1Trial register
At a glance

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi is the lead sponsor of 7 current clinical trials in our Turkey register. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Clinical Practice.

ClinicalTrials.gov trials by status

  • Recruiting229%
  • Not yet open114%
  • Active, closed229%
  • By invitation229%

Trials by phase

  • Not applicable686%
  • Observational114%
01

Clinical trials sponsored by Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

7 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Assessment Of Difficult Airway Predictors: A Prospective Comparison Of Upper Airway Ultrasound And Conventional Anthropometric Measures
NCT07309978 · ClinicalTrials.gov ↗ · Prediction of Difficult Airway, Difficult Airway Intubation
Observational Recruiting 2025-12 Turkey
The Effect of Placental Cord Drainage on the Third Stage of Labor and the Amount of Postpartum Bleeding
NCT07279545 · ClinicalTrials.gov ↗ · Postpartum Hemorrhage
Not applicable Recruiting 2025-11 Turkey
The Effect of Technology-Based Education Given to Mothers During the Transition to Complementary Feeding on Infant Development, Transition to Complementary Feeding Behavior, and Mothers' Anxiety Levels
NCT07487493 · ClinicalTrials.gov ↗ · Complementary Feeding, Pediatric Nurse
Not applicable Not yet open 2026-03 Turkey
The Effect of QR Code-Supported Perioperative Education Material Used in Clinical Practice
NCT06889077 · ClinicalTrials.gov ↗ · Clinical Practice, Nursing Education, Nursing Students
Not applicable By invitation 2024-12 Turkey
Effect of Cold Water Spray on Swallowing Difficulty, Pain, and Thirst After Thyroid Surgery
NCT07879404 · ClinicalTrials.gov ↗ · Swallowing Difficulties, Thirst, Thyroidectomy
Not applicable By invitation 2026-10 Turkey
Development and Usability Evaluation of an Arm Circumference Measurement Tool For Patients Undergoing Breast Surgery
NCT07154771 · ClinicalTrials.gov ↗ · Breast Surgery, Breast Cancer, Lymphedema
Not applicable Active, closed 2025-07 Turkey
The Effects of Different Time Reminder On Surgical Hand Scrubing
NCT07005635 · ClinicalTrials.gov ↗ · Surgical Site Infection
Not applicable Active, closed 2025-04 Turkey

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Saglik Bilimleri Universitesi Gulhane Tip Fakultesi trials

15 conditions
Clinical Practice1Nursing Education1Nursing Students1Evidence Based Nursing1Prediction of Difficult Airway1Difficult Airway Intubation1Complementary Feeding, Pediatric Nurse1Swallowing Difficulties1Thirst1Thyroidectomy1Breast Surgery1Breast Cancer1Lymphedema1Surgical Site Infection1Postpartum Hemorrhage1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Turkey72

A trial with sites in more than one country appears in each of those registers.

04

Questions about Saglik Bilimleri Universitesi Gulhane Tip Fakultesi trials

How many clinical trials does Saglik Bilimleri Universitesi Gulhane Tip Fakultesi sponsor?

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi is the lead sponsor of 7 current trials on ClinicalTrials.gov in our Turkey register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Saglik Bilimleri Universitesi Gulhane Tip Fakultesi trials recruiting?

Yes. 2 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.